The possibility that the “missing” MOG-specific circulating B cell population could be in the CNS was suggested by a documented increase of anti-MOG IgG in spinal fluid from MS patients [49] and by the shared BCR clonotypes between blood and CSF [50]. This evidence concerns the gene MOG and myeloid sarcoma.